Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TESFA: Enhanced Azithromycin for Trachoma in Ethiopia
NCT03523156Phase 4Withdrawn
- Sponsor
- Emory University
- Start
- Jun 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of azithromycin in trachoma, sponsored by Emory University. Planned start Jun 2025; status: withdrawn.
02
Drugs
azithromycin
03
Conditions
trachoma
Beyond the preview
Go deeper on NCT03523156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03523156.